Welcome back to Money Movers. Take a look at the XBI biotech ETF on pace for its best year since 2020. And news breaking earlier from the Wall Street Journal that Johnson and Johnson is looking to buy Protagonist Therapeutics.Our ne next guest is a top shareholder in Protagonist and a longtime investor in the biotech space. Joining us now, RTW Investments managing partner and CIO, Dr. . Rod Wong.Dr. . Thank you for being here today. Um, so there's been a a string of acquisitions in this space in in recent w ...